JP2021523877A5 - - Google Patents

Info

Publication number
JP2021523877A5
JP2021523877A5 JP2020544255A JP2020544255A JP2021523877A5 JP 2021523877 A5 JP2021523877 A5 JP 2021523877A5 JP 2020544255 A JP2020544255 A JP 2020544255A JP 2020544255 A JP2020544255 A JP 2020544255A JP 2021523877 A5 JP2021523877 A5 JP 2021523877A5
Authority
JP
Japan
Prior art keywords
day
glp1r agonist
phenyl
agonist
glp1r
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020544255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523877A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030110 external-priority patent/WO2019217165A1/en
Publication of JP2021523877A publication Critical patent/JP2021523877A/ja
Publication of JP2021523877A5 publication Critical patent/JP2021523877A5/ja
Priority to JP2024081189A priority Critical patent/JP2024112903A/ja
Pending legal-status Critical Current

Links

JP2020544255A 2018-05-08 2019-05-01 Ｇｌｐ１ｒアゴニストの治療的使用 Pending JP2021523877A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024081189A JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862668384P 2018-05-08 2018-05-08
US62/668,384 2018-05-08
PCT/US2019/030110 WO2019217165A1 (en) 2018-05-08 2019-05-01 Therapeutic uses of glp1r agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024081189A Division JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Publications (2)

Publication Number Publication Date
JP2021523877A JP2021523877A (ja) 2021-09-09
JP2021523877A5 true JP2021523877A5 (enExample) 2022-05-17

Family

ID=66484210

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020544255A Pending JP2021523877A (ja) 2018-05-08 2019-05-01 Ｇｌｐ１ｒアゴニストの治療的使用
JP2024081189A Pending JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024081189A Pending JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Country Status (9)

Country Link
US (2) US20210023072A1 (enExample)
EP (1) EP3790549A1 (enExample)
JP (2) JP2021523877A (enExample)
KR (2) KR20260036616A (enExample)
AU (2) AU2019266114A1 (enExample)
CA (1) CA3090823A1 (enExample)
MX (1) MX2020008387A (enExample)
SG (1) SG11202007966UA (enExample)
WO (1) WO2019217165A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20221040A1 (es) 2019-10-25 2022-06-17 Gilead Sciences Inc Compuestos moduladores de glp-1r
CA3168543A1 (en) 2020-01-29 2021-08-05 Gilead Sciences, Inc. Glp-1r modulating compounds
EP4141008A4 (en) * 2020-04-01 2024-04-17 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. PHARMACEUTICALLY ACCEPTABLE ACID SALT OF GLP-1 RECEPTOR AGONIST FREE BASE, AND PREPARATION METHOD THEREFOR
JP2023528565A (ja) * 2020-04-01 2023-07-05 ハンジョウ ジョンメイ フアドン ファーマシューティカル シーオー．，エルティーディー． Ｇｌｐ－１受容体アゴニストの結晶形ａおよびその調製法
US20230348412A1 (en) * 2020-05-28 2023-11-02 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Method for preparing glp-1 receptor agonist
TW202227455A (zh) * 2020-09-21 2022-07-16 美商維特衛治療有限責任公司 異喹啉衍生物的無定形形式
WO2022109182A1 (en) 2020-11-20 2022-05-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
EP4304711A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
WO2022192430A1 (en) 2021-03-11 2022-09-15 Gilead Sciences, Inc. Glp-1r modulating compounds
PL4271672T3 (pl) 2021-04-21 2026-04-20 Gilead Sciences, Inc. Karboksybenzimidazolowe związki modulujące glp-1r
KR102920994B1 (ko) 2024-05-20 2026-02-02 (주)인벤티지랩 오르포르글리포론 또는 이의 약학적으로 허용되는 염을 포함하는 마이크로 입자 및 이의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002534512A (ja) * 1999-01-15 2002-10-15 ノボ ノルディスク アクティーゼルスカブ 非ペプチドｇｌｐ−１アゴニスト
KR101616737B1 (ko) 2008-03-07 2016-05-02 브이티브이 테라퓨틱스 엘엘씨 당뇨병 치료를 위한 옥사디아조안트라센 화합물
CA2757084C (en) 2009-03-30 2017-08-29 Transtech Pharma, Inc. Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
WO2011031620A1 (en) * 2009-09-11 2011-03-17 Transtech Pharma, Inc. Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same
JP2015510947A (ja) * 2012-03-22 2015-04-13 トランステック・ファーマ，エルエルシー 小分子ｇｌｐ１ｒアゴニストのトリス（ヒドロキシメチル）アミノメタン塩ならびにその医薬組成物および使用
WO2014113357A1 (en) * 2013-01-17 2014-07-24 Transtech Pharma, Llc Combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders

Similar Documents

Publication Publication Date Title
US20250325536A1 (en) Therapeutic uses of glp1r agonists
CN101511364B (zh) 用于糖尿病的治疗组合
JP6066144B2 (ja) 併用医薬
US20110269750A1 (en) Roflumilast for the treatment of diabetes mellitus
JP2018131450A5 (enExample)
JP2015044875A5 (enExample)
JP2016518438A5 (enExample)
JP2022529312A5 (enExample)
TWI519297B (zh) 使用雙醋瑞因之糖尿病輔助療法
KR20260027165A (ko) 의료 요법에서의 세마글루티드
CN116157132A (zh) 一种降低血糖的组合、应用和方法
US9241956B2 (en) Pharmaceutical preparation and method for treatment of diabetes
WO2006094942A1 (en) Roflumilast for the treatment of diabetes mellitus
RU2021130019A (ru) Состав низкодозовой тройной комбинации
JP2011105609A (ja) メトホルミンへの付加療法を含む２型糖尿病の治療方法
HK1137345A (en) Combination treatment for diabetes mellitus